Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 Laser vs Lidocaine for Dyspareunia in Breast Cancer Survivors
NCT03257670Unknown
- Sponsor
- University of Cincinnati
- Start
- Mar 2018
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in dyspareunia (2 arms), sponsored by University of Cincinnati. Primary endpoint: Female Sexual Function Index at 9 months. Status: unknown.
02
Conditions
dyspareunia
Beyond the preview
Go deeper on NCT03257670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03257670.